Immune effector cells via paracrine cytokines and cell–cell contact

Immune effector cells via paracrine cytokines and cell–cell contact refers to a complex physiological mechanism of immune activation rather than a single molecular target. This process involves the recruitment and stimulation of various immune cells, such as cytotoxic T lymphocytes and natural killer cells, through two primary pathways: the secretion of signaling proteins (paracrine cytokines like IL-2 or IFN-gamma) and direct physical interaction between cell surface receptors (cell-cell contact) (Alberts et al., Molecular Biology of the Cell, 2014). In the context of modern immunotherapy, such as CAR-T cell therapy or bispecific T-cell engagers (BiTEs), this mechanism is leveraged to amplify the anti-tumor response beyond the initial engineered cell-target interaction, often referred to as the bystander effect (June et al., Science, 2018). While highly effective for clearing malignant cells, the systemic activation of these pathways can lead to significant clinical challenges, including cytokine release syndrome (Shimabukuro-Vornhagen et al., Journal for ImmunoTherapy of Cancer, 2018). Consequently, this entry describes a multi-component biological process essential for therapeutic efficacy in oncology and infectious diseases (Janeway's Immunobiology, 2016).

Other names

Bystander immune activationParacrine and juxtacrine immune signalingImmune effector cell recruitmentSecondary immune response amplification

Activation and recruitment of endogenous immune cells through the secretion of soluble mediators (paracrine) and direct membrane-bound ligand-receptor interactions (cell-cell contact).